HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Consumer Health Brands Should Increase Value As Higher Prices Discourage Consumers – IRI

Executive Summary

At CHPA conference, IRI's lead for health care market data, Kristin Hornberger, said as manufacturers increase product prices in response to rising costs and inflationary pressures, they also should work to make their products more valuable to consumers.

You may also be interested in...



Is More Always Better? Vous Vitamin CEO Says Personalized Product Sales Grow On Fewer Doses

Brad Helfand says direct-to-consumer personalized vitamins firm is seeing “strong and growing demand for our personalized all-in-one multivitamin products,” indicating a trend of consumer interest in similar products. 

HBW Insight’s Key Takeaways From 2021: #2 Get Serious About Sustainability

In 2021 the consumer health industry ramped up its sustainability efforts, with many firms publishing ambitious “net zero” transition strategies. As 2022 gets underway, recyclable or reusable packaging and consumer behavior change stand out as priority areas for further work, alongside carbon emissions reduction. To counter potential accusations of “greenwashing,” companies must be truthful and transparent about their ESG progress.

L’Oreal Picks Up CeraVe Skin Care Via $1.3bn Deal With Valeant

The CeraVe, AcneFree and Ambi skin-care lines will change hands from Valeant Pharmaceuticals to L’Oreal under a deal announced Jan. 10, beefing up the latter’s dermatologist-aligned Active Cosmetics division.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS152320

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel